Home › Funds › QVIDTVM Management LLC › BIO
QVIDTVM Management LLC position in BIO
BIO RAD LABS INC · Industrials
QVIDTVM Management LLC reported holding 40,732 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 26.63% of its reported portfolio and ranking #1 among its reported holdings. QVIDTVM Management LLC has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How QVIDTVM Management LLC's BIO position evolved
QVIDTVM Management LLC first disclosed a stake in BIO in Q3 2023 at 69,171 shares (US$24.8M). The position peaked in Q1 2024 at 125,938 shares, worth US$43.6M. Across 13 filings, QVIDTVM Management LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 40,732 shares valued at US$15.4M — a reduction of -25,511 shares quarter over quarter.. Notable position changes include a 81% increase in Q4 2023 (shares rose 7% over the following quarter), a 34% trim in Q4 2025 (shares fell 8% over the following quarter), a 39% trim in Q3 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 69.17K | $24.79M | New |
| Q4 2023 | 125.04K | $40.37M | Add |
| Q1 2024 | 125.94K | $43.56M | Add |
| Q2 2024 | 125.94K | $34.39M | Hold |
| Q3 2024 | 125.94K | $42.14M | Hold |
| Q4 2024 | 118.95K | $39.08M | Reduce |
| Q1 2025 | 126.20K | $30.74M | Add |
| Q2 2025 | 126.08K | $30.43M | Hold |
| Q3 2025 | 126.48K | $35.46M | Hold |
| Q4 2025 | 83.48K | $25.29M | Reduce |
| Q1 2026 | 83.73K | $23.34M | Hold |
| Q2 2026 | 66.24K | $19.45M | Reduce |
| Q3 2026 | 40.73K | $15.38M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 25 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K sh · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K sh · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on QVIDTVM Management LLC
FAQ
How long has QVIDTVM Management LLC held BIO?
QVIDTVM Management LLC has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is QVIDTVM Management LLC's current position in BIO?
As of Q3 2026, QVIDTVM Management LLC holds 40.73K shares of BIO (BIO RAD LABS INC), valued at $15.38M, representing 26.63% of its reported portfolio and ranking #1.
Has QVIDTVM Management LLC been buying or selling BIO?
In the latest 13F filing (Q3 2026), QVIDTVM Management LLC reduced its position in BIO. The position peaked in Q1 2024 at 125.94K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.